Department of Biomedical Engineering, Yale University, New Haven, Conn., USA.
Cells Tissues Organs. 2012;195(1-2):15-25. doi: 10.1159/000331409. Epub 2011 Oct 25.
Despite substantial progress in the field of vascular tissue engineering over the past decades, transition to human models has been rather challenging. The limited replicative life spans of human adult vascular cells, and their slow rate of collagenous matrix production in vitro, have posed important hurdles in the development of mechanically robust and biologically functional engineered grafts. With the more recent advances in the field of stem cells, investigators now have access to a plethora of new cell source alternatives for vascular engineering. In this paper, we review various alternative cell sources made available more recently for blood vessel engineering and also present some recent data on the derivation of smooth muscle cells from human induced pluripotent stem cells.
尽管过去几十年来在血管组织工程领域取得了重大进展,但向人体模型的转变仍然具有挑战性。人类成年血管细胞的复制寿命有限,以及它们在体外产生胶原基质的速度较慢,这给机械强度高和生物学功能强的工程移植物的开发带来了重要障碍。随着干细胞领域的最新进展,研究人员现在可以获得大量新的血管工程细胞来源替代物。本文综述了最近用于血管工程的各种替代细胞来源,并介绍了一些关于从人诱导多能干细胞中获得平滑肌细胞的最新数据。